Boston Scientific Corporation BSX
NYSE
Recommendation
Dividend Power Score
Day's Range
$41.92$43.23
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.44% | 7.53% | 11.58% | 15.90% | 20.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.44% | 7.53% | 11.58% | 15.90% | 20.34% |
| Cost of Revenue | 12.18% | -2.73% | 9.20% | 9.42% | 16.55% |
| Gross Profit | -3.23% | 12.49% | 12.67% | 18.99% | 22.06% |
| SG&A Expenses | -3.33% | 5.07% | 11.52% | 13.77% | 11.46% |
| Depreciation & Amortization | 4.00% | 3.56% | 5.94% | 1.33% | 9.76% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.59% | 1.89% | 10.87% | 12.57% | 15.01% |
| Operating Income | -6.76% | 32.13% | 14.41% | 31.77% | 46.24% |
| Income Before Tax | -21.86% | 12.65% | 44.47% | 19.86% | 40.21% |
| Income Tax Expenses | -16.39% | 6.16% | -232.33% | 30.43% | -8.50% |
| Earnings from Continuing Operations | -23.18% | 13.84% | 99.26% | 19.43% | 60.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 0.00% | 0.00% | -50.00% | -- |
| Net Income | -22.91% | 13.80% | 98.96% | 18.94% | 60.98% |
| EBIT | -6.76% | 32.13% | 14.41% | 31.77% | 46.24% |
| EBITDA | -3.74% | 25.18% | 12.76% | 23.55% | 35.94% |
| EPS Basic | -21.16% | 14.56% | 97.92% | 18.24% | 59.97% |
| Normalized Basic EPS | -6.90% | 35.68% | 19.93% | 31.34% | 42.33% |
| EPS Diluted | -21.49% | 15.09% | 100.00% | 18.54% | 59.97% |
| Normalized Diluted EPS | -6.24% | 36.48% | 20.44% | 31.62% | 42.42% |
| Average Basic Shares Outstanding | -2.23% | -0.66% | 0.52% | 0.58% | 0.61% |
| Average Diluted Shares Outstanding | -2.91% | -1.25% | 0.13% | 0.38% | 0.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |